在化疗引起的心脏毒性的炎症
Elizabeth Hutchins1, Eric H Yang1,2, Ashley F Stein-Merlob3,4
1Division of Cardiology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Current cardiology reports
|October 8, 2024
概括
炎症驱动化疗引起的心脏毒性,特别是由环素引起的心肌病 (AIC). 了解这些炎症途径有助于早期发现,并为患者制定心脏保护策略.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 化疗,特别是人环素,可以引起心脏毒性.
- 人类循环素诱导的心肌病 (AIC) 是癌症患者的一个重大问题.
- 炎症在化疗引起的心脏毒性的发展中起着至关重要的作用.
研究的目的:
- 审查炎症在化疗引起的心脏毒性的作用.
- 专注于抗环素诱导心肌病 (AIC) 的炎症.
- 讨论AIC中早期检测和心脏保护的临床影响.
主要方法:
- 对与人环素相关的细胞水平炎症的审查.
- 分析炎症机制的临床影响.
- 对AIC检测中的生物标志物和成像新兴证据的审查.
主要成果:
- 在AIC中的关键炎症途径包括细胞因子释放,TLR激活和炎症酶激活.
- 炎症生物标志物和先进的成像显示早期AIC检测的希望.
- 传统和新型抗炎疗法都可以预防和治疗AIC.
结论:
- 了解AIC炎症为早期检测和有针对性的心脏保护提供了新的途径.
- 这种知识可以为其他形式的化疗诱导心脏毒性的策略提供信息.
- 向炎症对于管理环素心脏毒性至关重要.
相关概念视频
Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
152
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
152
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Pericarditis I: Introduction
2
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
2


